The California Pharmacy and Therapeutic (P&T) Committee will hold a hybrid meeting on April 16th at 12:30 PM PST to discuss key issues related to the workers' compensation drug formulary.

Agenda highlights include updates on the pharmaceutical fee schedule, biosimilars, cannabis coverage, and payments for topically applied drugs.

This meeting gives stakeholders the ability to receive key updates that may influence formulary changes, while also giving them the ability to voice any concerns. Healthesystems will be attending this meeting, and the Division of Workers' Compensation (DWC) encourages public comments on the formulary to be submitted to Formulary@dir.ca.gov.